This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Trelegy Ellipta 200-62.5-25 60S medication. The award, valued at $27,092.31, is a Firm Fixed Price Delivery Order contract with an ultimate completion date of August 14, 2024. The contract does not have a set-aside designation. AmerisourceBergen, through its Corporate Office Division, will be supplying this prescription drug to support military treatment facilities and other federal healthcare providers nationwide. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to the U.S. federal government.
Generated 11/12/24, 9:03 AM